Aeglea BioTherapeutics (AGLE) Halted Again on LUDP
- Wall Street hits record high for third day in a row
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
- Exclusive: Japan's TDK in talks to buy iPhone supplier InvenSense - sources
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Aeglea BioTherapeutics (NASDAQ: AGLE) Halted Again on LUDP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Interpace Diagnostics (IDXG) Halted on LUDP Following 196% Surge
- AstraZeneca (AZN) Says FDA Accepts First BLA for Durvalumab in Bladder Cancer with Priority Review
- Neovasc (NVCN) Shares Look to Pullback for Second Session
Create E-mail Alert Related CategoriesMomentum Movers, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!